Precancerous cells in the cervix are treated based on their grade, ranging from monitoring alone for mild changes to outpatient procedures that remove or destroy the abnormal tissue. About 60% of the mildest cases resolve on their own within a year, while higher-grade changes typically require a procedure to prevent them from progressing to cervical cancer over time.
How Precancerous Cells Are Graded
Precancerous cervical changes are classified into three grades based on how much of the cervical lining is affected by abnormal cells. CIN 1 (mild) means only the lower third of the tissue shows changes. CIN 2 and CIN 3 (moderate to severe) involve more of the tissue, with CIN 3 affecting nearly the full thickness. These changes become cancer only if they break through the basement membrane, the boundary between the surface layer and deeper tissue, which typically takes several years even in high-grade cases.
The grade directly determines how your care team approaches treatment. CIN 1 is usually monitored. CIN 2 and CIN 3 carry a higher risk of eventually becoming invasive cancer, so they’re almost always treated with a procedure.
When Monitoring Is the Right Approach
For CIN 1, the standard approach is watchful waiting rather than immediate treatment. These mild changes frequently clear up on their own, especially in younger people whose immune systems are more likely to suppress the underlying HPV infection driving the abnormal cell growth. Your doctor will schedule follow-up Pap tests and HPV tests at regular intervals to confirm the cells are returning to normal rather than progressing.
If CIN 1 persists for two years or shows signs of worsening on repeat testing, treatment may then be recommended. But jumping to a procedure right away for mild changes would mean treating many people whose bodies would have resolved the problem without intervention.
LEEP: The Most Common Procedure
Loop electrosurgical excision procedure, or LEEP, is the most widely used treatment for CIN 2 and CIN 3. A thin wire loop carrying an electrical current is passed over the cervix to cut away a layer of abnormal tissue. The electrical current simultaneously seals blood vessels as it cuts, so bleeding during the procedure is minimal. The entire process is done through a speculum in an office or outpatient setting, often with just a local anesthetic to numb the cervix.
The tissue removed during LEEP goes to a lab for examination. This is one of its key advantages: it doesn’t just treat the problem, it provides a sample that confirms exactly what grade of changes were present and whether the margins (edges) of the removed tissue are clear of abnormal cells.
Recovery from LEEP generally takes a few weeks. You can expect some watery or bloody discharge during healing. Most providers advise avoiding tampons, sexual intercourse, and heavy exercise for several weeks to give the cervix time to heal and reduce infection risk.
Cryotherapy
Cryotherapy destroys abnormal cells by freezing them. A metal probe is placed against the cervix, and the tissue is frozen in a cycle: three minutes of freezing, five minutes of thawing, then another three minutes of freezing. This double-freeze approach is recommended over a single freeze for better results. The frozen tissue dies and is gradually shed by the body.
Cryotherapy works well when the abnormal area covers 75% or less of the visible cervix and the probe can fully cover the lesion. For larger lesions or those extending into the cervical canal, an excisional procedure like LEEP is preferred instead. Unlike LEEP, cryotherapy doesn’t produce a tissue sample for the lab, so it’s typically used when the diagnosis is already well established through prior biopsy.
Cold Knife Conization
Cold knife conization, sometimes called a cone biopsy, removes a cone-shaped section of tissue from the cervix using a surgical scalpel rather than an electrical loop. It’s more precise than LEEP and can remove more tissue, making it the preferred option in specific situations: when abnormal cells extend high into the cervical canal where a loop can’t reach, when the full extent of the lesion can’t be seen during colposcopy, or when there’s concern about possible early invasion that needs careful evaluation.
Because it’s a more involved surgery, cold knife conization is typically performed in an operating room under general or regional anesthesia. Recovery takes somewhat longer than LEEP, and there’s a slightly higher risk of bleeding. It’s reserved for cases where the additional precision or tissue removal is genuinely needed.
Laser Ablation
A carbon dioxide laser can be used to either vaporize abnormal tissue on the surface of the cervix or to perform a cone-shaped excision similar to cold knife conization. Bleeding during the procedure is rare. In one study comparing the two laser approaches, recurrence of precancerous changes occurred in about 7% of patients after laser vaporization and about 6% after laser excision, with complications being uncommon overall. Laser treatment is less widely available than LEEP or cryotherapy and tends to be offered at specialized centers.
How Effective Treatment Is
The success rates for these procedures are high. In a large study following over 3,200 women after conization, only 3.5% developed recurrent high-grade changes over an average follow-up of nearly four years. When recurrence did happen, it appeared about two years after the initial treatment on average. This means the vast majority of people who undergo treatment are cured with a single procedure, though long-term monitoring remains important.
HPV Vaccination After Treatment
Getting the HPV vaccine after a procedure like LEEP appears to significantly reduce the chance of precancerous cells returning. In one study, recurrence requiring a second LEEP occurred in 16.5% of unvaccinated patients compared to 7.1% of those who received the vaccine after their procedure. The protective effect was even more striking for severe recurrences (CIN 3 or carcinoma in situ), where vaccination cut the risk by roughly 80%. If you haven’t been vaccinated or haven’t completed the full vaccine series, getting it after treatment is worth discussing with your provider.
Follow-Up After Treatment
Ongoing monitoring is essential even after successful treatment. The standard approach involves combined testing with both a Pap test and an HPV test at six months and again at 24 months after the procedure. When both of those tests come back negative, the risk of developing high-grade changes over the following five years drops below 1%, which is comparable to the risk in the general screened population.
If the edges of the removed tissue showed residual abnormal cells, or if there’s uncertainty about whether all the affected tissue was removed, monitoring is more intensive. In those cases, combined testing at 6 months and 18 months is followed by annual testing that continues for up to 20 years, regardless of the original grade. This longer surveillance catches the small number of cases where abnormal cells persist or return, allowing retreatment before any progression to cancer.